Generics Could Be Exceptional
We often read about the high cost of healthcare in this country. In fact, much of the world is faced with issues relating to rising healthcare costs. Perhaps the healthcare cost problems of other nations are not as acute as ours (because they spend less), but medical care costs are a global concern.
This is among the tailwinds propelling the generic drug market. When a proprietary drug comes off patent, generic makers step in and start selling lower-priced equivalents. But all is not perfect in this market. Competition is stiff, and after 2013, the value of patent expirations will decline. Of course, growth in the industry is heavily dependent on the expiration of patents of valuable drugs. That said, the generic drug market looks strong over the long term and should continue to perform well in the future....418 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.